Abstract: Lymphoid neoplasms occurring in three different (C3H/He, C57BL/6, and B6C3F 1 ) strains of female mice after injection of the bone-seeking and alpha-emitting radionuclide, 2 39 Pu citrate were compared by immunohistochemistry with those from the alkylating agent, N-methyl-N-nitrosourea (MNU)-injected mice. There was a variety of phenotypes from either T-cell to B-cell or histiocytic lineages in lymphoid neoplasms of the control, salineinjected mice. While strain differences were noted in the incidence and proportion, lymphoid neoplasms occurring early after 239 Pu-injection were, however, characterized by B220 + phenotypes but negative for both T-cell-specific markers (Thy 1, CD3) and B-cell markers (CD5, CD19, CD79b) to be classified into pre-B-cell lymphomas derived from progenitor B-cells. In contrast, almost all the MNU-induced lymphomas were shown to be CD3 + or rarely Thy 1 + but B220 -T-lymphoblastic lymphomas. These results indicate differences in immunophenotypic expression but also might reflect different carcinogenic processes between chemical-and radiation-induced murine lymphomas. (J Toxicol Pathol 2003; 16: 93-102) 
Introduction
Murine lymphoid neoplasms have been well described in the NFS strain congenic for ecotropic murine leukemia virus [1] [2] [3] to be mostly classified into B-cell lymphomas matching well the histopathological and immunophenotypic classification of human non-Hodgkin's lymphoid neoplasms 4, 5 . Although naturally occurring as well as chemical-induced lymphomas in a certain inbred or genetically engineered strain of aged mice have also been reported [6] [7] [8] , their phenotypes varied from B-cell to T-cell lineages. It has long been recognized that external X-or γ-radiation and neutron exposures under certain exposure regimens induce more frequently thymic lymphomas as well as myeloid leukemias in some strains of mice 9, 10 . Nonthymic but malignant systemic lymphomas have been occasionally found in mice as well as osteosarcomas following internal radiation exposures of skeletal bones by t h e i n j e c t i o n o f α -o r β -e m i t t i n g b o n e -s ee k i n g radionuclides 1 1 , 1 2 , although their morphologic and immunohistochemical features have not been fully elucidated as compared to those of congenic strains as above described.
We have also encountered malignant lymphomas occurring early in three different (C3H/HeN, C57BL/6J and their hybrid B6C3F 1 ) strains of mice following injection of an α-emitting bone-seeker, 239 Pu citrate, and tentatively defined their phenotypes as precursor B-cell lymphomas with Thy 1 -but B220 + surface markers 13, 14 . Further immunohistochemical characterization, using the other T-or B-lineage-specific surface markers, was performed in the present study by comparing the differences in the onset periods, frequencies, and phenotypes among lymphoid n e o p l a s m s f r o m th e c o n tr o l , 2 3 9 P u -i n j e ct e d a n d methylnitrosourea (MNU)-injected mice. In addition, since phenotypic expression of lymphomyeloid neoplasms are closely related to their ontogenic and differentiation stages from bone marrow precursors, the differences in the carcinogenic processes were discussed including susceptibilty to T-or B-lineage neoplastic cells from bone marrow stem cells between radiation-and chemical-induced murine lymphomas.
Materials and Methods

Experimental animals
Specific-pathogens (Salmonella spp., Mycoplasma spp, HVJ, and MHV)-free female mice of three strains, C3H/HeN (C3H), C57BL/6J (C57) and their hybrid B6C3F 1 (BC3), were purchased from the breeding facility (Japan SLC Co.), and all the animals were housed 10 per polycarbonate cage (22 cm-width × 38 cm-depth × 20 cm-hight), given a commercial diet (Funabashi Farm Co.) with water ad libitum, and kept under a barrier-filtered air condition before and after all the experiments. The animal rooms were maintained on a 12-hr light:dark cycle at an air temperature of 23 ± 1.0°C and in a humidity of 55 ± 5.0%. The animal care included a weekly change of cages and a daily check of the animals' condition during their lifetime. All the experimental treatments were performed with the approval of the institution's animal use committee.
Experimental design
For the control group, 60 mice of each strain at 100 to 120 days old were injected intraperitoneally (ip) with 0.1 ml of saline as the carrier control. For the groups of plutonium (Pu), each of 30 age-matched mice of each strain was also injected ip with a different radioactivity; 100, 500, 1000, 5000, or 10000 Bq of 239 Pu citrate (Pu) in saline solution (pH 6.8-7.2) prepared by the previously described method 13 . For the group of methylnitrosourea (MNU), 60 mice of each strain initially at 100 days old were injected ip 5 times weekly with 40 mg/kg body weight of N-methyl-Nnitrosourea (Sigma) prepared by the previously described method 15 . All of these groups were kept in a closed-hood rack during their lifetime.
Histopathology and immunohistochemistry
All the groups of animals of each strain were autopsied after death or killed under anesthesia with ether on the occasion of a moribund state to examine gross lesions of the main organs and skeletal bones. All the tissue specimens including tumors were fixed in the mixture of 10% phosphate-buffered formalin and 4% paraformaldehyde for 5 days, cut into small pieces, processed with graded ethanol and xylene in an automatic tissue processor, and embedded in paraffin to prepare 5-to 6-µm-thick serial sections on a silanized glass slide (DAKO). For histopathological examinations of lymphoid neoplasms, one of serial sections was routinely stained with hematoxylin and eosin (HE), and the other unstained sections were treated for immunohistochemical typing using specific marker antibodies as follows: monoclonal rat IgG antibodies to CD45R (B220, RA3-6B2; Pharmingen), CD90 (Thy 1, G7; Pharmingen), and CD5 (Ly 1, 53-7.3; Pharmingen) as well as polyclonal goat antibodies to CD3-ε (M-20; Santa Cruz), CD19 (R-20; Santa Cruz), and CD79b (V-18; Santa Cruz). Briefly, deparaffinized and rehydrated sections were pretreated with 0.3% hydrogen peroxide in methanol at room temperature for 20 min to inactivate (B) and BC3 (C) strain mice after injection of saline (control), 239 Pu citrate (Pu), or methylnitrosourea (MNU). The columns indicate the number of tumor-bearing animals from all the control, Pu-or MNU-groups in every 100-day-interval periods after the injection.
endogenous peroxidase activity. After washing with 0.05% Tris-buffered saline (TBS, pH 7.6), sections were immersed into an antigen retrieval solution (DAKO) and heated to 90-95°C for 25 min in a microwave oven to unmask cell surface antigens. Following washing with TBS, sections were incubated with normal rat or normal goat serum at room temperature for 1 hr to block any nonspecific Fc-binding of a secondary antibody, and then incubated with each of the primary antibodies (10 µg/ml for monoclonal antibodies and 1:100 dilution for polyclonal antibodies) at 4°C for overnight. After washing with TBS, sections were reacted with biotinylated secondary anti-rat or anti-goat IgG antibody (Vectastain Elite ABC kit; Vector Lab) at room temperature for 1 hr, and then coupled with avidin-biotinimmunoperoxidase complex (ABC) at room temperature for 30 min. After washing with TBS, sections were treated with the substrate, 3,3'-diaminobenzidine tetrachloride (DAB) to visualize immunoreactivity, and counterstained with hematoxylin. As negative controls, normal rat or goat serum was applied on the sections instead of primary antibodies, and then processed under similar conditions to those described above. On light microscopic examinations of these stainings, differential diagnosis and histological classification were performed according to those of morphologic or some immunohistochemical criteria for murine lymphoid neoplasms as described 16, 17 .
Statistics
All the cases of lymphoid neoplasms from the control, Pu and MNU groups were selected and analysed for survival periods and competing risks with the other tumors, particularly bone tumors, or non-neoplastic death by the Kaplan-Meier method using the log-rank and Peto-Wilcoxon tests as described previously 14 .
As each of the solid tumors was considered to be independently induced following Pu-or MNU-injections, the standard errors (SE) for the incidence of lymphoid neoplasms as well as the other tumors in each group were calculated according to the following equation as 
Results
Appearance periods and frequencies of lymphoid neoplasms
The periods for the appearance of lymphoid neoplasms at autopsy were differed among three strains of the control mice examined, but were mostly late over 400-500 days after injection of saline as shown in Fig. 1 . As compared to the controls, the appearance periods of lymphoid neoplasms from Pu-injected C3H mice were only found within 200 days, while those from C57 and BC3 mice were relatively early within 200-400 days after the injection of 5000 Bq or more of Pu. In contrast, lymphoid neoplasms from three strains of MNU-injected mice appeared much earlier during the periods from 30 to 150 days after the injection.
The frequencies of solid tumors as well as myeloid leukemias found in the control, Pu-, and MNU-groups of three strains of mice are summarized in Table 1 . While strain differences were noted, total incidences of lymphoid neoplasms as well as the other solid tumors from Pu-injected mice were reduced than those of the controls because of the competition with early and highly induced bone tumors as described previously 14 . The incidences of lymphoid neoplasms occurred much earlier in three strains of MNUinjected mice, however, increased predominantly up to approximately 1.5-to 2.0-fold of the control values, and therefore bone and the other solid tumors nor myeloid leukemias were scarcely found within 150 days after the injection of MNU. Although total incidences of lymphoid neoplasms in all the Pu-injected animals were lower than the control and MNU-injected animals, the dose responses apperared to be inversely proportional to the injected radioactivity of Pu (Fig. 2) . Thus, none or less lymphoid neoplasms were found in three strains of mice after injection of Pu radioactivity of 100-1000 Bq as compared to the controls, while their incidences again but slightly increased in the dose ranges more than 5000 Bq. In contrast, the dose responses for the incidences of bone tumors from the three strains of mice were proportional to the injected doses increasing from 100 to 1000 Bq, and then declined at the doses of more than 5000 Bq (data not shown).
Histological and immunohistochemical appearances of lymphoid neoplasms
Although strain differences were noted, variable types of lymphoid neoplasms were observed in the control, saline-injected mice. Many of them appeared grossly to be systemic lymphomas in which the whole-body lymph n o d e s w er e e n la r g e d , a c c o m p a n ied m o s t ly wi th hep atosplen omegaly and som etim es with thy mic enlargement. Histologically, these neoplasms appeared to be composed of medium to large, round, ovoid or polygonal cells with relatively abundant and pale cytoplasm, and with chromatin-rich nuclei and prominent nucleoli. The growth pattern of neoplastic cells was almost diffuse or sometimes follicular, and distributed in the whole areas of the lymph nodes, thymus, and spleen, and in the sinusoidal and periportal areas of the liver, associated with perivascular or peribronchiolar infiltration in the kidney and lung. (Fig.  3C) or CD79b + B-cell lineage lymphomas were rarely or scarcely found in the control animals. Only a few of the lymphoid neoplasms from the control mice were grossly found to be localized either in local lymph nodes, in the spleen or occasionally in the liver. These neoplasms were characterized by diffuse or focal proliferation of spindleshaped or polygonal cells with eosinophilic and brilliant cytoplasms, and frequently mixed with multinucleated giant cells (Fig. 3D ). Since none of the above T-or B-cell lineagespecific markers were positive, these neoplasms were diagnosed as histiocytic lymphomas.
Such histopathological and immunohistochemical features of the lymphomas from the control animals as described above changed into more immature or progenitor phenotypes in Pu-injected mice. Grossly, almost all the neoplastic lesions were distributed in the whole-body lymph nodes, liver, and spleen, all of which appeared to be more pale and swollen than the controls. The histological appearances of such systemic lymphoma cells from Pu-injected animals were almost similar to the above described findings in the controls, but rather showing more extensive growth and leukemic infiltration of neoplastic cells in the liver (Fig. 4A) or more diffuse proliferation accompanied with typical starry sky effects by increased tingible-body macrophages in the lymphoid follicles (Fig. 4B) . The most prominent and specific features were shown by immunohistochemical staining for these lymphomas; thus, only B220 + progenitor B-cell (pre-B-cell) lymphomas were more predominantly observed in the liver (Fig. 4C) and spleen or lymph nodes (Fig. 4D) Contrary to pre-B-cell lymphomas from Pu-injected mice, the MNU-induced lymphoid neoplasms, were characterized by a specified spectrum of T-lymphoblastic lymphoma; grossly prominent thymic enlargement as well as enlargement of whole-body lymph nodes and spleen; histologically diffuse or follicular proliferation of medium to large, and cohesive lymphoblasts with mitoses and starry sky effects in the thymus (Fig. 5A ) and other lymphoid organs. These lymphoma cells exclusively expressed CD3 
Immunophenotypic distribution of lymphoid neoplasms
Based on the above findings, immunohistochemical typing of lymphoid neoplasms from the control, Pu, and MNU groups are summarized in Table 2 . Despite strain differences in the positive proportion of each surface marker, lymphomas from the control groups were variably positive for T-cell lineage markers (Thy 1, CD3), and B-cell lineage markers (B220, CD5, CD19). While early occurring lymphomas from the Pu groups were rather positive for pre-B-cell marker, B220, or B-cell markers (CD5, CD19) than Tcell markers (Thy 1, CD3) , almost all the MNU-induced lymphomas expressed T-cell-specific marker, CD3, but not B-cell lineage markers (CD19, CD79b). According to such immunophenotypic characterization and histological criteria as described 16, 17 , murine lymphomas are classified into the following phenotypes: B220 proportion of each lineage to all the neoplasms in Fig. 6 . While almost 50-60% of neoplasms from the control groups were classified into T-cell lineage, the proportions of pre-Bcell lineage prominently increased in the Pu groups up to 80% in C3H, or 45% both in C57 and BC3 strains of mice. Total proportions of B-cell lineage neoplasms including Bcell lymphomas ranging 20-32% in the control groups increased up to 65-100% but the proportions of T-cell lineage, instead, decreased down to 30% or less in the Pu groups. On the contrary, the proportion of T-cell lineage neoplasms exclusively increased up to 80-90% in the MNU groups.
Discussion
Although internal radiation exposures by bone-seeking radionuclides occasionally induce lymphoid neoplasms as well as osteosarcomas in mice 11, 12 , the entity for pathological features and the differences from those by exposures to external radiations or chemical carcinogens have not been fully elucidated. The present study first characterized the histopathological features and immunophenotypes of murine lymphoid neoplasms occurring relatively early in three strains of mice having different spontaneous and radiationinduced tumor spectra after the injection of α-emitting, bone-seeking 239 Pu citrate. As compared to the salineinjected (control) and chemical carcinogen (MNU)-injected groups, frequencies of lymphoid neoplasms from Puinjected mice were much lower despite a slight increase at higher doses of more than 5000 Bq, which were assumed to be a competing dose range with osteosarcomas occurring relatively early as described previously 13, 14 . Morphologic and immunohistochemical typing of lymphoid neoplasms from Pu-injected mice revealed that 
CD79b
phenotypes specific to early B lymphomyeloid progenitor cells as described for X-ray-induced leukemias in BCL-2 transgenic mice 19 . As compared to the phenotypic distribution of lymphoid neoplasms from the control group, such progenitor B-cell lymphomas classified into pre-B-cell lymphomas were more predominant in Pu-groups despite the strain differences in the proportion varied from 45 to 80%, and total B-cell lineage neoplasms including CD5 Myeloid leukemias and thymic lymphomas were scarcely or not found in the three strains of Pu-injected mice in the present study. While external radiation exposures more frequently induce both of these lymphomyeloid neoplasms in some strains (C57BL/6, BALB/c, and CBA/H) of mice 10 , even internal α-radiation exposures by boneseeking radionuclides significantly induce myeloid leukemias and osteosarcomas in CBA/H strain mice [20] [21] [22] . Thus, strain differences in radiation-induced lymphomyeloid neoplasms, not only with the incidences, latency periods, and systemic or localized growth, but also phenotypes such as T-or B-cell lymphomas and myelogenous leukemias, reflect the genetic control of the susceptibility to radiationinduced lymphomyeloid neoplasms as described in either resistant, susceptible or recombinant congenic strains 23 . The susceptibility to external X-or γ-radiation-induced acute myeloid leukemias or thymic lymphomas in both CBA/H and C57BL/6 strains of mice currently appears to depend on the specific loss of heterozygosity over 7 chromosomes or genomic instability 24, 25 . The cellular and molecular mechanisms for radiationinduced lymphomyeloid neoplasms were not fully elucidated, as compared to the chemical-induced neoplasms. For example, mutation frequency of a tumor suppressor gene, p53 was lower both in γ-ray-and MNU-induced thymic lymphomas from C57BL/6J mice suggesting no major role of p53 mutations on the lymphomagenesis 26 , while codon 12 Ki-ras mutation is closely associated with early stage of MNU-induced thymic lymphomas but not detected in any stages of γ-ray-induced thymic lymphomas 27 . The K-ras mutations of X-ray-induced thymic lymphomas from B6C3F 1 mice are described to be closely associated with loss of heterozygosity on specific chromosomes 28 , although its significance for lymphomagenesis remains unknown. So far, any evidence for genetic alterations specific to radiation-induced murine lymphomas was not verified, whereas cyclin D 1 29 was highly expressed by all pre-B and B-cell lymphomas, and BCL-6 gene alterations 30 might be involved in diffuse large B cell lymphomas, both from NFS congenic strain for ecotropic murine leukemia virus, as similarly shown by human B-cell lymphomas. It is only a speculation that since pluripotent hemopoietic progenitor cells could be radiosensitive but also target cells for lymphomyeloid neoplasms after long-term and lower dose rate exposures to α-emitting bone-seekers 31, 32 , the susceptibility to either myeloid leukemias or B-cell or T-cell lineage lymphomas might be modulated by such alterations of the hemopoietic microenvironment through radiation damage.
In conclusion, the present study first describes imm unophenotypic c haracteriz ation of lymphoid neoplasms from three different strains of mice after the internal radiation exposures to an α-emitting and boneseeking radionuclide, 239 Pu citrate. The results indicate predominant occurrence of B220 + pre-B-cell lymphomas, as compared to exclusive increase of CD3 + T-lymphoblastic lymphomas induced by an alkylating agent, MNU. Such immunophenotypic difference might also reflect different carcinogenic processes between chemical-and radiationinduced murine lymphomas.
